Topic: Biology

Scientists at Stanford Medicine and their collaborators have developed a universal nasal spray vaccine that shields against a broad range of respiratory viruses, bacteria, and allergens. The vaccine provides wide-ranging protection in the lungs that lasts for months.

Scientists have long dreamed of creating a single vaccine that can protect against many different infectious threats. Now, researchers at Stanford Medicine and their collaborators have taken a major step towards making this vision a reality. In a new study, they developed an experimental universal vaccine that shields against a broad range of respiratory viruses, bacteria, and even allergens. The vaccine is given intranasally, like a nasal spray, and provides wide-ranging protection in the lungs that lasts for months.

The findings show that vaccinated mice were protected from SARS-CoV-2 and other coronaviruses, Staphylococcus aureus and Acinetobacter baumannii (common hospital-acquired infections), as well as house dust mites (a common allergen). The level of protection across so many respiratory threats exceeded expectations.

The study's lead author is Haibo Zhang, PhD, a postdoctoral scholar in Pulendran's lab. If similar results are achieved in people, a single vaccine could potentially replace multiple yearly shots for seasonal respiratory illnesses and provide rapid protection if a new pandemic virus emerges.

Why It Matters

This breakthrough has the potential to simplify vaccination schedules and provide rapid protection against emerging threats. As India continues to grapple with COVID-19 and other respiratory infections, this universal nasal spray vaccine could be a game-changer in the fight against infectious diseases.

Key Facts

• The experimental vaccine provides wide-ranging protection in the lungs that lasts for months
• Vaccinated mice were protected from SARS-CoV-2 and other coronaviruses, Staphylococcus aureus and Acinetobacter baumannii, as well as house dust mites
• The study's lead author is Haibo Zhang, PhD, a postdoctoral scholar in Pulendran's lab

Key Terms

Antigen specificity

A common strategy used by traditional vaccines to present the immune system with a recognizable piece of a pathogen

Implications

This breakthrough has the potential to simplify vaccination schedules and provide rapid protection against emerging threats. As India continues to grapple with COVID-19 and other respiratory infections, this universal nasal spray vaccine could be a game-changer in the fight against infectious diseases.